CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

(2018) Cristina Mussini et al.   BMC Medicine

Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial

(2018) J.R. Blanco et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

(2018) Josep M Llibre et al.   LANCET

Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence

(2017) C Orkin et al.   HIV MEDICINE

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

(2017) Rajesh T. Gandhi et al.   PLoS Pathogens

CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy

(2016) Jessica L. Castilho et al.   AIDS

The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment

(2016) Enrique Bernal Morell et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients

(2016) Sergio Serrano-Villar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR

(2016) A. Saracino et al.   JOURNAL OF CLINICAL VIROLOGY

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio

(2016) Mar Masiá et al.   MEDICINE

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

(2015) Nikolas Itaru Wada et al.   AIDS

CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

(2015) Cristina Mussini et al.   Lancet HIV

Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio

(2014) Sergio Serrano-Villar et al.   PLoS One